Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_provenance.
- befree-2016 importedOn "2016-02-19" NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_provenance.
- NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_assertion wasGeneratedBy ECO_0000203 NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_provenance.
- NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_assertion wasDerivedFrom befree-2016 NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_provenance.
- NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_assertion SIO_000772 1380280 NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_provenance.
- NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_assertion evidence source_evidence_literature NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_provenance.
- NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_assertion description "[The results in different types of leukaemia were (number of patients with detectable mdr1 RNA/total number of patients; median number of transcripts per cell in samples with detectable mdr1 RNA); de novo untreated acute myelocytic leukaemia (AML): 20/44; 0.7, secondary acute myelocytic leukaemia: 8/13; 1.1, acute lymphocytic (ALL) and undifferentiated leukaemia: 5/14; 0.6, relapsed leukaemia: 7/15; 0.7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412595.RAnl8Unw1oA2UGFi6xy6OlPaNGHugrN_oZunoTGD83Qck130_provenance.